Biovie BIVI
Biovie: securities offering
- Form
- S-1
- Filed
- Importance
- Notable
- Accession
- 0001520138-25-000198
- Document
- S-1
- Exhibit 1.1
- Underwriting agreement
- Exhibit 4.17
- Pre-funded common stock purchase warrant
- Exhibit 4.18
- Common stock purchase warrant
- Exhibit 4.20
- Warrant agent agreement
Not explained yet; the original is on EDGAR.
Securities offering
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- GT Biopharma GTBP public float $9M, Jun 30, 2025
- Talphera TLPH public float $8M, Jun 30, 2025
- Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
- TherapeuticsMD TXMD public float $9M, Jun 30, 2025
- Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025